Prosecution Insights
Last updated: July 17, 2026

Fox Rothschild LLP - Jhu

34 pending office actions • 5 clients • 31 examiners • 25 art units • 0 of 34 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Quality Metrics (n=135257 apps, methodology: how we score firms)

84.2%
Allowance Rate
n=135257
+0.58σ
Allowance Rate (norm)
n=135257
3.3
OAs to Allowance
n=76960
-0.18σ
OAs to Allow (norm)
n=76960
1069 days
Time to Allowance
n=76960
+9.6pp
Interview Lift
n=135257
27.3%
RCE Rate
n=135257
1.9%
Appeal Rate
n=135257

Rejection Performance (% of received rejections ultimately overcome)

81.6%
§101 Overcome
n=2507
85.0%
§102 Overcome
n=10501
81.4%
§103 Overcome
n=44761
89.9%
§112 Overcome
n=9165

Specialization & Scale

G06F, A61K, H04L
Top CPC Subclasses
12%
Top-3 CPC Share
n=135257
55
Practitioners
n=135257
2459.2
Apps / Practitioner
n=135257

Portfolio Summary

34
Total Pending OAs
19
Non-Final OAs
15
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (1)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (3%)
23
Medium (68%)
6
Easy (18%)
4
Unknown (12%)

Rejection Statute Mix

BucketCases
§101 only1 (3%)
§103 only20 (59%)
§102 only2 (6%)
§112 only3 (9%)
Double-patenting only3 (9%)
Double-patenting + other1 (3%)
No statute on record4 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

30
Life Sciences
88% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
6% of docket
2
Business / Other
6% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

340 h
Manual time on pending OAs
68 h
Time saved (low, 20%)
119 h
Time saved (mid, 35%)
3.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MINCHELLA, KAITLYN L 3 26.8% +22.1%
KENNEDY, SARAH JANE 2 0.0% +0.0%
WRIGHT, SARAH C 1 41.1% +46.4%
LIEB, JEANETTE M 1 79.9% +16.9%
BELL, SARA ELIZABETH 1 69.8% +38.0%
MOSS, NATALIE M 1 31.1% +16.6%
HONRATH, MARC D 1 74.6% +30.2%
GANGLE, BRIAN J 1 76.7% +15.1%
HAM, JIEUN 1 60.0% +53.3%
HUSSAINI, ATTIYA SAYYADA 1 59.0% +16.8%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17622037 COMPOSITIONS AND METHODS FOR LYME DISEASE IVICH, FERNANDO NMN 31d overdue
17204892 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER MINCHELLA, KAITLYN L 5d overdue
17790293 IN SITU RNA ANALYSIS USING PROBE PAIR LIGATION KENNEDY, SARAH JANE 72d
18972277 IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION KENNEDY, SARAH JANE
17842893 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER MINCHELLA, KAITLYN L
17056726 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER MINCHELLA, KAITLYN L

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18286185 TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL BELL, SARA ELIZABETH 26d overdue
18202066 MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME HAM, JIEUN 15d overdue
17204892 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER MINCHELLA, KAITLYN L 5d overdue
18670928 NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION WRIGHT, SARAH C
18293692 COMPOSITIONS AND METHODS FOR TREATING MELANOMA LIEB, JEANETTE M
18237744 NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY MOSS, NATALIE M
18223331 MULTI-IMAGER COMPATIBLE ROBOT FOR IMAGE-GUIDED INTERVENTIONS AND FULLY AUTOMATED BRACHYTHERAPY SEED HONRATH, MARC D
18217857 BACTERIAL BIOFILMS AND CANCER GANGLE, BRIAN J

Client Portfolio (5 clients)

Top Art Units

Art UnitApps
16823
16853
16432
16412
16182
16752
16191
16251
16531
37911

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18972277 IN SITU NUCLEIC ACID ANALYSIS USING PROBE PAIR LIGATION The Johns Hopkins University KENNEDY, SARAH JANE 1682 §112 Final Rejection Pending Dec 06, 2024
18670928 NANOFIBER-HYDROGEL COMPOSITES FOR ENHANCED SOFT TISSUE REPLACEMENT AND REGENERATION The Johns Hopkins University WRIGHT, SARAH C 1619 §112 Non-Final OA Pending May 22, 2024
18293692 COMPOSITIONS AND METHODS FOR TREATING MELANOMA Johns Hopkins University LIEB, JEANETTE M §103 Non-Final OA Pending Jan 30, 2024
18286185 TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL The Johns Hopkins University BELL, SARA ELIZABETH 1625 §103 Non-Final OA 26d overdue Pending Oct 09, 2023
18237744 NANOFIBER-HYDROGEL COMPOSITES FOR CELL AND TISSUE DELIVERY The Johns Hopkins University MOSS, NATALIE M 1653 §103 Non-Final OA Pending Aug 24, 2023
18223331 MULTI-IMAGER COMPATIBLE ROBOT FOR IMAGE-GUIDED INTERVENTIONS AND FULLY AUTOMATED BRACHYTHERAPY SEED The Johns Hopkins University HONRATH, MARC D 3791 §103 Final Rejection Pending Jul 18, 2023
18217857 BACTERIAL BIOFILMS AND CANCER National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government GANGLE, BRIAN J 1645 §103 Non-Final OA Pending Jul 03, 2023
18202066 MAP KINASE PATHWAY TARGETS FOR THE TREATMENT OF MARFAN SYNDROME The Johns Hopkins University HAM, JIEUN 1643 §103 Non-Final OA 15d overdue Pending May 25, 2023
18037508 INTEGRATED ROBOTIC INTRAOCULAR SNAKE The Johns Hopkins University HUSSAINI, ATTIYA SAYYADA 3792 §103 Final Rejection Pending May 17, 2023
18247144 INTEGRATED PROTEOMIC BIOMARKERS FOR THE DETECTION OF AGGRESSIVE PROSTATE CANCER The Johns Hopkins University DENT, ALANA HARRIS 1643 §103 Non-Final OA Pending Mar 29, 2023
18027067 NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR The Johns Hopkins University SALVOZA, M FRANCO G 1672 §103 Non-Final OA 84d Pending Mar 17, 2023
18025367 METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME The Johns Hopkins University ORWIG, KEVIN S 3991 §103 Final Rejection Pending Mar 08, 2023
18015684 COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY The Johns Hopkins University ROONEY, NORA MAUREEN 1641 §103 Non-Final OA Pending Jan 11, 2023
18004030 METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA Renmin Hospital Of Wuhan University SITTON, JEHANNE SOUAYA 1682 §112 Final Rejection 45d overdue Pending Dec 30, 2022
18013864 METHODS TO GLYCOENGINEER PROTEINS The Johns Hopkins University DAHLE, CHUN WU 1641 §102 Final Rejection 63d Pending Dec 29, 2022
17873980 IN SITU FORMING COMPOSITE MATERIAL FOR TISSUE RESTORATION The Johns Hopkins University JONES, DAMERON LEVEST 1618 §103 Non-Final OA Pending Jul 26, 2022
17790293 IN SITU RNA ANALYSIS USING PROBE PAIR LIGATION The Johns Hopkins University KENNEDY, SARAH JANE 1682 DPOther Final Rejection 72d Pending Jun 30, 2022
17789099 ENHANCING EXPRESSION OF LINE-1 ENCODED ORF2P FOR CANCER THERAPEUTICS The Johns Hopkins University BEANE, RANDALL L 1654 §103 Final Rejection 3d overdue Pending Jun 24, 2022
17842893 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER The Johns Hopkins University MINCHELLA, KAITLYN L 1685 DP Non-Final OA Pending Jun 17, 2022
17770531 A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY The Johns Hopkins University REGA, KYLE THOMAS 1636 §103 Final Rejection Pending Apr 20, 2022
17769705 EXTRACELLULAR VESICLE-BASED AGENTS AND METHODS FOR THE TREATMENT OF NEUROPATHIC DISORDERS UNIVERSITY OF WASHINGTON WANG, CHANG YU 1675 §103 Non-Final OA 20d Pending Apr 15, 2022
17767389 HIGHLY MULTIPLEXED DETECTION OF NUCLEIC ACIDS The Johns Hopkins University ALAM, DANYAL HASSAN 1600 DP Final Rejection Pending Apr 07, 2022
17641417 ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE The Johns Hopkins University SCHLIENTZ, LEAH H 1618 §103 Final Rejection 35d overdue Pending Mar 08, 2022
17622037 COMPOSITIONS AND METHODS FOR LYME DISEASE The Johns Hopkins University IVICH, FERNANDO NMN 1678 §101 Final Rejection 31d overdue Pending Dec 22, 2021
17604255 Methods for Detecting and Treating Esophageal Cancer The Johns Hopkins University CHUNDURU, SURYAPRABHA 1681 §103 Final Rejection 19d overdue Pending Oct 15, 2021
17598690 METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER The Johns Hopkins University LU, CHENG 1642 DP Non-Final OA Pending Sep 27, 2021
17204892 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER The Johns Hopkins University MINCHELLA, KAITLYN L 1685 Other Non-Final OA 5d overdue Pending Mar 17, 2021
17194177 GLP-1R AGONIST AND METHODS OF TREATMENT The Johns Hopkins University HIBBERT, CATHERINE S 1658 §103 Non-Final OA 4d overdue Pending Mar 05, 2021
17180696 NAÏVE HUMAN EMBRYONIC VASCULAR PROGENITOR CELLS AND METHODS OF TREATMENT The Johns Hopkins University GONZALES, JOSEPHINE MARIA 1631 Other Non-Final OA Pending Feb 19, 2021
17139665 COMPOSITIONS AND METHODS TO ACCELERATE RESOLUTION OF ACUTE LUNG INFLAMMATION The Johns Hopkins University CRAIGO, BAHAR ALAWI 1699 Other Non-Final OA Pending Dec 31, 2020
17056726 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER The Johns Hopkins University MINCHELLA, KAITLYN L 1685 Other Final Rejection Pending Nov 18, 2020
16758030 BIOMIMETIC PLATFORMS TO MODEL VASCULAR PATHOPHYSIOLOGY, DIAGNOSTICS, AND THERAPY The Johns Hopkins University WESTON, ALYSSA G 1633 §102 Final Rejection Pending Apr 21, 2020
16753567 IMPLANTABLE BIOREACTOR AND METHODS FOR MAKING AND USING SAME The Johns Hopkins University BROWE, DAVID 1617 §103 Non-Final OA 17d overdue Pending Apr 03, 2020
16379763 IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS The Johns Hopkins University DUTT, ADITI 1675 §103 Non-Final OA Pending Apr 09, 2019

Managing Fox Rothschild LLP - Jhu's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month